MMRGlobal CEO Robert H. Lorsch Clear Channel Interview on "The
Traders Network" Hosted by Michael Yorba Recap
LOS ANGELES, CA--(Marketwired - Nov 15, 2013) - MMRGlobal, Inc.
(OTCQB: MMRF) CEO Robert H. Lorsch was interviewed November 14th on
Clear Channel's business talk radio show The Traders Network hosted
by Michael Yorba. The show, which aired on Dallas-Ft. Worth DFW
1190AM radio station, focused on MMRGlobal's patented
MyMedicalRecords Personal Health Record (PHR) products and services
and the Company's intellectual property that has put it at the
intersection of the government's healthcare IT mandates by
providing patients with online access to their health information
through a Personal Health Record. MMRGlobal is a leading provider
of Personal Health Records, MyEsafeDepositBox storage solutions and
MMRPro electronic document management and imaging systems for
healthcare professionals.
Live interview archive (12min, 1sec):
http://www.yorbamedia.com/images/stories/audio/TN111413SEG1.mp3
Network: Clear Channel Station: DFW 1190AM Host:
Michael Yorba
Lorsch discussed how government initiatives, primarily the
HITECH Act and also the Affordable Care Act are driving the
adoption of PHRs and the electronic transmission and exchange of
patient information. He pointed out that Meaningful Use Stage 2
under the HITECH Act requires eligible professionals to provide
more than 50% of patients the ability to view online, download and
transmit their health information through a Personal Health Record
or similar patient portal within four days of the information being
available to the healthcare professional.
Lorsch stated, "Our product (MyMedicalRecords) is the most
comprehensive turnkey PHR that connects to any hospital or
healthcare provider anywhere in the world. We hold patents on
methods and systems to connect patients to healthcare systems and
there are government requirements out there that call for getting
patients to participate in the management of their medical
information."
Lorsch noted multiple paths to success, "We sell direct to
consumer, we sell OEM, we license to OEMs and we get to enforce our
intellectual property in the health information technology
marketplace. It is difficult with the depth of our portfolio
for companies to not somehow meet us somewhere in the food
chain." Lorsch discussed how billions have been allocated by
the U.S. government toward the Affordable Care Act and
HITECH. Continued Lorsch, "Around the world in the 12
countries where our patents are already issued, it is a $1 trillion
market. Almost every country in the world is going to eHealth
and we are at the forefront of the eHealth market."
"Patent royalty enforcement is going to make your earnings
skyrocket," stated The Traders Network Host Michael
Yorba. "This is a guy who knows what he is doing."
"It's always such a great experience to be able to stand up and
tell our story in such a public news medium as it was with this
interview where we really have a chance to explain what we're doing
and how we're going to get it done. We look forward to doing more
of these types of events going into 2014," stated Mr. Lorsch.
About MMRGlobal MMRGlobal, Inc., through its wholly-owned
operating subsidiary, MyMedicalRecords, Inc., provides secure and
easy-to-use online Personal Health Records ("PHRs") and electronic
safe deposit box storage solutions, serving consumers, healthcare
professionals, employers, insurance companies, financial
institutions, retail pharmacies, and professional organizations and
affinity groups. The MyMedicalRecords PHR enables individuals and
families to access their medical records and other important
documents, such as birth certificates, passports, insurance
policies and wills, anytime from anywhere using the Internet.
MyMedicalRecords is built on proprietary, patented technologies to
allow documents, images and voicemail messages to be transmitted
and stored in the system using a variety of methods, including fax,
phone, or file upload without relying on any specific electronic
medical record platform to populate a user's account. The Company's
professional offering, MMRPro, is designed to give physicians'
offices an easy and cost-effective solution to digitizing
paper-based medical records and sharing them with patients through
an integrated patient portal. Through its merger with Favrille,
Inc. in January 2009, the Company acquired intellectual property
biotech assets that include anti-CD20 antibodies and data and
samples from its FavId™/Specifid™ vaccine clinical trials for the
treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about
MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video
tutorials of the Company's products and services at
www.mmrtheater.com.
A www.1800PublicRelations.com PR Event
Forward-Looking Statements Statements in this press release and
interview that are not strictly historical in nature, including,
without limitation, intellectual property enforcement actions,
infringement claims or litigation, intellectual property licenses,
and future performance, management's expectations, beliefs,
intentions, estimates or projections, constitute "forward-looking
statements." Such forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause MMR's
actual results to be materially different from historical results
or from any results expressed or implied by such forward-looking
statements. Some can be identified by the use of words (and their
derivations) such as "need," "possibility," "potential," "intend,"
"offer," "development," "if," "negotiate," "when," "begun,"
"believe," "achieve," "will," "estimate," "expect," "maintain,"
"plan," and "continue," or the negative of these words. Actual
outcomes and results of operations and the timing of selected
events may differ materially from the results predicted, and any
reported results should not be considered as an indication of
future performance. Such statements are necessarily based on
assumptions and estimates and are subject to various risks and
uncertainties, including those relating to the possible invalidity
of the underlying assumptions and estimates and possible changes or
developments in economic, business, industry, market, legal and
regulatory circumstances and conditions and actions taken or
omitted to be taken by third parties, including customers,
suppliers, business partners, potential licensees, competitors and
legislative, judicial and other governmental authorities and
officials. Factors that could cause or contribute to such
differences include, but are not limited to: unexpected outcomes
with respect to intellectual property enforcement actions, claims
of intellectual property infringement and general intellectual
property litigation; our ability to maintain, develop, monetize and
protect our patent portfolio for both MMR's health IT and
biotechnology intellectual property assets in the U.S. and
internationally; the timing of milestone payments in connection
with licensing our intellectual property; our ability to establish
and maintain strategic relationships; changes in our relationships
with our licensees; the risk MMR's products are not adopted or
viewed favorably by the healthcare community and consumer retail
market; business prospects, results of operations or financial
condition; risks related to the current uncertainty and instability
in financial and lending markets, including global economic
uncertainties; the timing and volume of sales and installations;
the length of sales cycles and the installation process; the
market's acceptance of new product and service introductions;
competitive product offerings and promotions; changes in government
laws and regulations including the 2009 HITECH Act and changes in
Meaningful Use and the 2010 Affordable Care Act; future changes in
tax legislation and initiatives in the healthcare industry;
undetected errors in our products; the possibility of interruption
at our data centers; risks related to third party vendors; risks
related to obtaining and integrating third-party licensed
technology; risks related to a security breach by third parties;
risks associated with recruitment and retention of key personnel;
other litigation matters; uncertainties associated with doing
business internationally across borders and territories; and
additional risks discussed in MMR's filings with the Securities and
Exchange Commission. MMR is providing this information as of the
date of this release and, except as required by applicable law,
does not undertake any obligation to update any forward-looking
statements contained in this release as a result of new
information, future events or otherwise.
Media Contacts: Matthew Bird President MUNCmedia Public
Relations (917) 409-8211 matt.bird@muncmedia.com For MMRGlobal:
Michael Selsman Public Communications Co. (310) 922-7033
ms@publiccommunications.biz